A November 2025 Kaiser Family Foundation poll found that 1 in 8 U.S. adults have tried a GLP-1 medication for weight loss, ...
Ozempic maker's lawsuit, FDA enforcement could curtail sales of less expensive, compounded, versions of popular weight loss ...
Some patients in a clinical trial of one new drug lost so much weight that they became concerned and dropped out.
Australian researchers warn GLP-1 weight-loss drugs may cause scurvy, the historic "pirate disease," due to poor nutrition and vitamin C deficiency risks.
Make sure the clinician knows what other medications you’re taking, and set up a real follow-up plan to adjust these ...
The recent withdrawal of Hims & Hers’ GLP-1 pill raises questions about the safety and effectiveness of compounded medications ...
Emma Dyer says she collapsed on her bathroom floor and began vomiting blood after buying jabs online.
But a new Oxford University study published in The BMJ suggests the benefits may be short-lived. Researchers found that people tend to regain weight quickly after discontinuing weight-loss medications ...
Soaring in popularity, GLP-1 medications—from weekly injections to newly available pills—are rapidly reshaping how Americans ...
Drugmakers Novo Nordisk and Eli Lilly are battling it out in the GLP-1 weight loss market. The pill version of Novo Nordisk's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results